Global Type 2 Diabetes Therapeutics Industry Research Report 2020, Forecast to 2025

May 2020 | 105 pages | ID: G2396EA56F34EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Type 2 Diabetes Therapeutics market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Type 2 Diabetes Therapeutics is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Type 2 Diabetes Therapeutics industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Type 2 Diabetes Therapeutics by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Type 2 Diabetes Therapeutics market are discussed.

The market is segmented by types:

• Insulins
• DPP-4 Inhibitors
• GLP-1 Receptor Agonists
• SGLT-2 Inhibitors

It can be also divided by applications:

• Drugstore
• Hospital
• Others

And this report covers the historical situation, present status and the future prospects of the global Type 2 Diabetes Therapeutics market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Novo Nordisk
• Biocon
• Eli Lily
• Sanofi
• Daiichi Sankyo
• Merck
• Astellas Pharma
• AstraZeneca
• Boehringer Ingelheim

Report Includes:

• xx data tables and xx additional tables
• An overview of global Type 2 Diabetes Therapeutics market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Type 2 Diabetes Therapeutics market
• Profiles of major players in the industry, including - Novo Nordisk, Biocon, Eli Lily, Sanofi, Daiichi Sankyo.....

Research objectives

• To study and analyze the global Type 2 Diabetes Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Type 2 Diabetes Therapeutics market by identifying its various subsegments.
• Focuses on the key global Type 2 Diabetes Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Type 2 Diabetes Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Type 2 Diabetes Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Type 2 Diabetes Therapeutics Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Type 2 Diabetes Therapeutics Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 TYPE 2 DIABETES THERAPEUTICS INDUSTRY OVERVIEW

2.1 Global Type 2 Diabetes Therapeutics Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Type 2 Diabetes Therapeutics Global Import Market Analysis
  2.1.2 Type 2 Diabetes Therapeutics Global Export Market Analysis
  2.1.3 Type 2 Diabetes Therapeutics Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Insulins
  2.2.2 DPP-4 Inhibitors
  2.2.3 GLP-1 Receptor Agonists
  2.2.4 SGLT-2 Inhibitors
2.3 Market Analysis by Application
  2.3.1 Drugstore
  2.3.2 Hospital
  2.3.3 Others
2.4 Global Type 2 Diabetes Therapeutics Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Type 2 Diabetes Therapeutics Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Type 2 Diabetes Therapeutics Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Type 2 Diabetes Therapeutics Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Type 2 Diabetes Therapeutics Manufacturer Market Share
  2.4.5 Top 10 Type 2 Diabetes Therapeutics Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Type 2 Diabetes Therapeutics Market
  2.4.7 Key Manufacturers Type 2 Diabetes Therapeutics Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Type 2 Diabetes Therapeutics Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Type 2 Diabetes Therapeutics Industry Impact
  2.7.1 How the Covid-19 is Affecting the Type 2 Diabetes Therapeutics Industry
  2.7.2 Type 2 Diabetes Therapeutics Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Type 2 Diabetes Therapeutics Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Type 2 Diabetes Therapeutics Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL TYPE 2 DIABETES THERAPEUTICS MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Type 2 Diabetes Therapeutics Sales Market Share by Region
4.2 Global Type 2 Diabetes Therapeutics Revenue Market Share by Region (2015-2019)
4.3 Global Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Type 2 Diabetes Therapeutics Market Size Detail
  4.4.1 North America Type 2 Diabetes Therapeutics Sales Growth Rate (2015-2020)
  4.4.2 North America Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Type 2 Diabetes Therapeutics Market Size Detail
  4.5.1 Europe Type 2 Diabetes Therapeutics Sales Growth Rate (2015-2020)
  4.5.2 Europe Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Type 2 Diabetes Therapeutics Market Size Detail
  4.6.1 Japan Type 2 Diabetes Therapeutics Sales Growth Rate (2015-2020)
  4.6.2 Japan Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Type 2 Diabetes Therapeutics Market Size Detail
  4.7.1 China Type 2 Diabetes Therapeutics Sales Growth Rate (2015-2020)
  4.7.2 China Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL TYPE 2 DIABETES THERAPEUTICS MARKET SEGMENT BY TYPE

5.1 Global Type 2 Diabetes Therapeutics Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Type 2 Diabetes Therapeutics Sales and Market Share by Type (2015-2020)
  5.1.2 Global Type 2 Diabetes Therapeutics Revenue and Market Share by Type (2015-2020)
5.2 Insulins Sales Growth Rate and Price
  5.2.1 Global Insulins Sales Growth Rate (2015-2020)
  5.2.2 Global Insulins Price (2015-2020)
5.3 DPP-4 Inhibitors Sales Growth Rate and Price
  5.3.1 Global DPP-4 Inhibitors Sales Growth Rate (2015-2020)
  5.3.2 Global DPP-4 Inhibitors Price (2015-2020)
5.4 GLP-1 Receptor Agonists Sales Growth Rate and Price
  5.4.1 Global GLP-1 Receptor Agonists Sales Growth Rate (2015-2020)
  5.4.2 Global GLP-1 Receptor Agonists Price (2015-2020)
5.5 SGLT-2 Inhibitors Sales Growth Rate and Price
  5.5.1 Global SGLT-2 Inhibitors Sales Growth Rate (2015-2020)
  5.5.2 Global SGLT-2 Inhibitors Price (2015-2020)

6 GLOBAL TYPE 2 DIABETES THERAPEUTICS MARKET SEGMENT BY APPLICATION

6.1 Global Type 2 Diabetes TherapeuticsSales Market Share by Application (2015-2020)
6.2 Drugstore Sales Growth Rate (2015-2020)
6.3 Hospital Sales Growth Rate (2015-2020)
6.4 Others Sales Growth Rate (2015-2020)

7 GLOBAL TYPE 2 DIABETES THERAPEUTICS MARKET FORECAST

7.1 Global Type 2 Diabetes Therapeutics Sales, Revenue Forecast
  7.1.1 Global Type 2 Diabetes Therapeutics Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Type 2 Diabetes Therapeutics Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Type 2 Diabetes Therapeutics Price and Trend Forecast (2020-2025)
7.2 Global Type 2 Diabetes Therapeutics Sales Forecast by Region (2020-2025)
  7.2.1 North America Type 2 Diabetes Therapeutics Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Type 2 Diabetes Therapeutics Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Type 2 Diabetes Therapeutics Production, Revenue Forecast (2020-2025)
  7.2.4 China Type 2 Diabetes Therapeutics Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF TYPE 2 DIABETES THERAPEUTICS INDUSTRY KEY MANUFACTURERS

8.1 Novo Nordisk
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Novo Nordisk Type 2 Diabetes Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Novo Nordisk News
8.2 Biocon
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Biocon Type 2 Diabetes Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Biocon News
8.3 Eli Lily
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Eli Lily Type 2 Diabetes Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Eli Lily News
8.4 Sanofi
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Sanofi Type 2 Diabetes Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Sanofi News
8.5 Daiichi Sankyo
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Daiichi Sankyo Type 2 Diabetes Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Daiichi Sankyo News
8.6 Merck
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Merck Type 2 Diabetes Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Merck News
8.7 Astellas Pharma
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Astellas Pharma Type 2 Diabetes Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Astellas Pharma News
8.8 AstraZeneca
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 AstraZeneca Type 2 Diabetes Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 AstraZeneca News
8.9 Boehringer Ingelheim
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 Boehringer Ingelheim Type 2 Diabetes Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 Boehringer Ingelheim News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Type 2 Diabetes Therapeutics Picture
Figure Research Programs/Design for This Report
Figure Global Type 2 Diabetes Therapeutics Market by Regions (2019)
Table Global Market Type 2 Diabetes Therapeutics Comparison by Regions (M USD) 2019-2025
Table Global Type 2 Diabetes Therapeutics Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Type 2 Diabetes Therapeutics by Type in 2019
Figure Insulins Picture
Figure DPP-4 Inhibitors Picture
Figure GLP-1 Receptor Agonists Picture
Figure SGLT-2 Inhibitors Picture
Table Global Type 2 Diabetes Therapeutics Sales by Application (2019-2025)
Figure Global Type 2 Diabetes Therapeutics Sales Market Share by Application in 2019
Figure Drugstore Picture
Figure Hospital Picture
Figure Others Picture
Table Global Type 2 Diabetes Therapeutics Sales by Manufacturer (2018-2020)
Figure Global Type 2 Diabetes Therapeutics Sales Market Share by Manufacturer in 2019
Table Global Type 2 Diabetes Therapeutics Revenue by Manufacturer (2018-2020)
Figure Global Type 2 Diabetes Therapeutics Revenue Market Share by Manufacturer in 2019
Table Global Type 2 Diabetes Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Type 2 Diabetes Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Type 2 Diabetes Therapeutics Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Type 2 Diabetes Therapeutics Market
Table Key Manufacturers Type 2 Diabetes Therapeutics Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Type 2 Diabetes Therapeutics
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Type 2 Diabetes Therapeutics Sales (K Units) by Region (2015-2020)
Table Global Type 2 Diabetes Therapeutics Sales Market Share by Region (2015-2019)
Figure Global Type 2 Diabetes Therapeutics Sales Market Share by Region (2015-2019)
Figure Global Type 2 Diabetes Therapeutics Sales Market Share by Region in 2018
Table Global Type 2 Diabetes Therapeutics Revenue (Million US$) by Region (2015-2020)
Table Global Type 2 Diabetes Therapeutics Revenue Market Share by Region (2015-2020)
Figure Global Type 2 Diabetes Therapeutics Revenue Market Share by Region (2015-2020)
Figure Global Type 2 Diabetes Therapeutics Revenue Market Share by Region in 2019
Table Global Type 2 Diabetes Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Type 2 Diabetes Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table North America Type 2 Diabetes Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Type 2 Diabetes Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table Europe Type 2 Diabetes Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Type 2 Diabetes Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table Japan Type 2 Diabetes Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Type 2 Diabetes Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table China Type 2 Diabetes Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Type 2 Diabetes Therapeutics Sales by Type (2015-2020)
Table Global Type 2 Diabetes Therapeutics Sales Market Share by Type (2015-2020)
Figure Global Type 2 Diabetes Therapeutics Sales Market Share by Type in 2019
Table Global Type 2 Diabetes Therapeutics Revenue by Type (2015-2020)
Table Global Type 2 Diabetes Therapeutics Revenue Market Share by Type (2015-2020)
Figure Global Type 2 Diabetes Therapeutics Revenue Market Share by Type in 2019
Figure Global Insulins Sales Growth Rate (2015-2020)
Figure Global Insulins Price (2015-2020)
Figure Global DPP-4 Inhibitors Sales Growth Rate (2015-2020)
Figure Global DPP-4 Inhibitors Price (2015-2020)
Figure Global GLP-1 Receptor Agonists Sales Growth Rate (2015-2020)
Figure Global GLP-1 Receptor Agonists Price (2015-2020)
Figure Global SGLT-2 Inhibitors Sales Growth Rate (2015-2020)
Figure Global SGLT-2 Inhibitors Price (2015-2020)
Table Global Type 2 Diabetes Therapeutics Sales by Application (2015-2020)
Table Global Type 2 Diabetes Therapeutics Sales Market Share by Application (2015-2020)
Figure Global Type 2 Diabetes Therapeutics Sales Market Share by Application in 2019
Figure Global Drugstore Sales Growth Rate (2015-2020)
Figure Global Hospital Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Type 2 Diabetes Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Type 2 Diabetes Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Type 2 Diabetes Therapeutics Price and Trend Forecast (2020-2025)
Table Global Type 2 Diabetes Therapeutics Sales (K Units) Forecast by Region (2020-2025)
Figure Global Type 2 Diabetes Therapeutics Production Market Share Forecast by Region (2020-2025)
Figure North America Type 2 Diabetes Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Type 2 Diabetes Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Type 2 Diabetes Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Type 2 Diabetes Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Type 2 Diabetes Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Type 2 Diabetes Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Type 2 Diabetes Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Type 2 Diabetes Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Novo Nordisk Company Profile
Figure Type 2 Diabetes Therapeutics Product Picture and Specifications of Novo Nordisk
Table Type 2 Diabetes Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novo Nordisk Type 2 Diabetes Therapeutics Market Share (2018-2020)
Table Novo Nordisk Main Business
Table Novo Nordisk Recent Development
Table Biocon Company Profile
Figure Type 2 Diabetes Therapeutics Product Picture and Specifications of Biocon
Table Type 2 Diabetes Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biocon Type 2 Diabetes Therapeutics Market Share (2018-2020)
Table Biocon Main Business
Table Biocon Recent Development
Table Eli Lily Company Profile
Figure Type 2 Diabetes Therapeutics Product Picture and Specifications of Eli Lily
Table Type 2 Diabetes Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Eli Lily Type 2 Diabetes Therapeutics Market Share (2018-2020)
Table Eli Lily Main Business
Table Eli Lily Recent Development
Table Sanofi Company Profile
Figure Type 2 Diabetes Therapeutics Product Picture and Specifications of Sanofi
Table Type 2 Diabetes Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sanofi Type 2 Diabetes Therapeutics Market Share (2018-2020)
Table Sanofi Main Business
Table Sanofi Recent Development
Table Daiichi Sankyo Company Profile
Figure Type 2 Diabetes Therapeutics Product Picture and Specifications of Daiichi Sankyo
Table Type 2 Diabetes Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Daiichi Sankyo Type 2 Diabetes Therapeutics Market Share (2018-2020)
Table Daiichi Sankyo Main Business
Table Daiichi Sankyo Recent Development
Table Merck Company Profile
Figure Type 2 Diabetes Therapeutics Product Picture and Specifications of Merck
Table Type 2 Diabetes Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Merck Type 2 Diabetes Therapeutics Market Share (2018-2020)
Table Merck Main Business
Table Merck Recent Development
Table Astellas Pharma Company Profile
Figure Type 2 Diabetes Therapeutics Product Picture and Specifications of Astellas Pharma
Table Type 2 Diabetes Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Astellas Pharma Type 2 Diabetes Therapeutics Market Share (2018-2020)
Table Astellas Pharma Main Business
Table Astellas Pharma Recent Development
Table AstraZeneca Company Profile
Figure Type 2 Diabetes Therapeutics Product Picture and Specifications of AstraZeneca
Table Type 2 Diabetes Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure AstraZeneca Type 2 Diabetes Therapeutics Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Boehringer Ingelheim Company Profile
Figure Type 2 Diabetes Therapeutics Product Picture and Specifications of Boehringer Ingelheim
Table Type 2 Diabetes Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Boehringer Ingelheim Type 2 Diabetes Therapeutics Market Share (2018-2020)
Table Boehringer Ingelheim Main Business
Table Boehringer Ingelheim Recent Development
Table of Appendix